
Dr. Reddy's Laboratories Limited RDY
€ 11.90
2.12%
Quartalsbericht 2022-Q1
hinzugefügt 27.06.2022
Dr. Reddy's Laboratories Limited Kurshistorie 2011-2026 | RDY
Kurshistorie Jährlich Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 65.4 | 71 | 40.1 | 37 | 36.5 | 43.7 | 44.5 | 48.2 | 38.9 | 31.4 | 27.5 |
Alle Zahlen in INR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 71 | 27.5 | 44 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 21.91 | 2.34 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Aptorum Group Limited
APM
|
0.91 | $ 0.94 | 5.23 % | $ 6.91 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 22.7 | 3.37 % | $ 3.76 B | ||
|
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
91.2 | $ 102.78 | -2.55 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
4.37 | $ 4.16 | 1.84 % | $ 445 M | ||
|
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 23.75 | 2.09 % | $ 3.02 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.45 | 0.35 % | $ 386 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.03 | 4.12 % | $ 4.99 M | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | ||
|
ContraFect Corporation
CFRX
|
2.07 | - | -5.16 % | $ 5.39 M | ||
|
Cardiff Oncology
CRDF
|
1.74 | $ 1.76 | 2.03 % | $ 118 M | ||
|
BioXcel Therapeutics
BTAI
|
1.26 | $ 1.11 | 4.25 % | $ 13.6 M | ||
|
Cabaletta Bio
CABA
|
2.82 | $ 3.02 | 2.43 % | $ 303 M | ||
|
Cara Therapeutics
CARA
|
1 | - | -3.03 % | $ 260 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | ||
|
CASI Pharmaceuticals
CASI
|
8.4 | - | - | $ 35.4 M | ||
|
CymaBay Therapeutics
CBAY
|
32.3 | - | - | $ 3.45 B |